These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15754026)

  • 1. Modulation of the CXC-chemokine expression profile on tumor cells by the immunosuppressive drug mycophenolate mofetil.
    Engl T; Relja B; Natsheh I; Makarevic J; Müller I; Beecken WD; Jonas D; Blaheta RA
    Int J Mol Med; 2005 Apr; 15(4):641-7. PubMed ID: 15754026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy.
    Engl T; Makarević J; Relja B; Natsheh I; Müller I; Beecken WD; Jonas D; Blaheta RA
    BMC Cancer; 2005 Jan; 5():4. PubMed ID: 15644133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate mofetil increases adhesion capacity of tumor cells in vitro.
    Blaheta RA; Bogossian H; Beecken WD; Jonas D; Hasenberg C; Makarevic J; Ogbomo H; Bechstein WO; Oppermann E; Leckel K; Cinatl J
    Transplantation; 2003 Dec; 76(12):1735-41. PubMed ID: 14688525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix.
    Engl T; Relja B; Blumenberg C; Müller I; Ringel EM; Beecken WD; Jonas D; Blaheta RA
    Life Sci; 2006 Mar; 78(16):1784-93. PubMed ID: 16263140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells.
    Leckel K; Beecken WD; Jonas D; Oppermann E; Coman MC; Beck KF; Cinatl J; Hailer NP; Auth MK; Bechstein WO; Shipkova M; Blaheta RA
    Clin Exp Immunol; 2003 Nov; 134(2):238-45. PubMed ID: 14616783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monocyte/endothelial cell interactions and monocyte adhesion molecule expression by the immunosuppressant mycophenolate mofetil.
    Glomsda BA; Blaheta RA; Hailer NP
    Spinal Cord; 2003 Nov; 41(11):610-9. PubMed ID: 14569262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid induces expression of neutrophil chemoattractants of the CXC chemokine family in endothelial cells.
    Engl T; Natsheh I; Müller I; Beecken WD; Jonas D; Blaheta RA
    Int J Clin Pharmacol Ther; 2004 Oct; 42(10):568-74. PubMed ID: 15516027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models.
    Voisard R; Viola S; Kaspar V; Weber CM; von Müller L; Baur R; Gastrock-Balitsch I; Hombach V
    BMC Cardiovasc Disord; 2005 May; 5(1):9. PubMed ID: 15890069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailability.
    Koehl GE; Wagner F; Stoeltzing O; Lang SA; Steinbauer M; Schlitt HJ; Geissler EK
    Transplantation; 2007 Mar; 83(5):607-14. PubMed ID: 17353782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma.
    Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH
    Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mycophenolic acid on endothelial cells.
    Huang Y; Liu Z; Huang H; Liu H; Li L
    Int Immunopharmacol; 2005 Jun; 5(6):1029-39. PubMed ID: 15829418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cxc chemokine receptor expression on human endothelial cells.
    Murdoch C; Monk PN; Finn A
    Cytokine; 1999 Sep; 11(9):704-12. PubMed ID: 10479407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative and overadditive effects of everolimus and mycophenolate mofetil in pancreas and lung cancer cells in vitro.
    Stracke S; Ramudo L; Keller F; Henne-Bruns D; Mayer JM
    Transplant Proc; 2006 Apr; 38(3):766-70. PubMed ID: 16647466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
    Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
    Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo lymphocyte proliferative function is severely inhibited in renal transplant patients on mycophenolate mofetil treatment.
    Hutchinson P; Jose M; Atkins RC; Holdsworth SR
    Transpl Immunol; 2004; 13(1):55-61. PubMed ID: 15203129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus.
    Lewis MJ; D'Cruz D
    Lupus; 2005; 14 Suppl 1():s17-26. PubMed ID: 15803927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
    Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
    Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role and clinicopathologic significance of CXC chemokine ligand 16 and chemokine (C-X-C motif) receptor 6 expression in gastric carcinomas.
    Xing YN; Xu XY; Nie XC; Yang X; Yu M; Xu HM; Liu YP; Takano Y; Zheng HC
    Hum Pathol; 2012 Dec; 43(12):2299-307. PubMed ID: 22863086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil.
    Roos N; Poulalhon N; Farge D; Madelaine I; Mauviel A; Verrecchia F
    J Pharmacol Exp Ther; 2007 May; 321(2):583-9. PubMed ID: 17272676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
    Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
    Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.